Post-approval studies (Phase 4)Study completedNCT02070692
What this trial is testing
Tamoxifen for the Treatment of Unfavorable Bleeding in Contraceptive Implant Users
Who this might be right for
Menstruation Disturbances
Oregon Health and Science University 56